Lasmiditan Succinate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Lasmiditan Succinate Tablet (tablet) from Eli Lilly And Co. with status No longer listed by FDA. The shortage was first posted on Nov 3, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Eli Lilly And Co.
- Package NDC
- 0002-4312-61
- Dosage Form
- Tablet
- Presentation
- Reyvow, Tablet, 50 mg (NDC 0002-4312-61)
- Initial Posting
- Nov 3, 2025